Statistics

Total Visits

Views
Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naive Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial31

Select a period of time:

Number of views in the range

Views
Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naive Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial24

Views

Views
May 20245
June 20240
July 20243
August 20249
September 20246
October 20241
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States21
United Kingdom1
 

Top cities views

Views
Chicago7
Fort Worth2
Prineville1